GENEGUT

🎯 GENEGUT is a Horizon Europe project (GA No. 101057491), developing a first-in-class oral RNA-based therapy to treat ileal Crohn's Disease. Coordinated by the University College Cork School of Pharmacy and APC Microbiome Ireland. 📌 Through a patient-centred approach and grown out of the recent Cost Action UNGAP (CA16205), GENEGUT brings together a patient association with renowned researchers, expert clinical scientists, SMEs and large pharma companies with expertise and patented technologies in global proteomics, nanotechnologies, cyclodextrin synthesis, multicellular models, drug delivery systems and production as well as innovation management, stakeholder involvement and science communication. Page reflects only the views of GENEGUT.